• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺动脉高压症状聚类分析:一项初步研究。

Cluster analysis of symptoms in pulmonary arterial hypertension: a pilot study.

机构信息

University of Pennsylvania, School of Nursing, 418 Curie Blvd., Philadelphia, PA 19104-4217, USA.

出版信息

Eur J Cardiovasc Nurs. 2012 Mar;11(1):51-61. doi: 10.1177/1474515111429649. Epub 2012 Jan 11.

DOI:10.1177/1474515111429649
PMID:22357779
Abstract

BACKGROUND

Pulmonary arterial hypertension (PAH) is characterized by elevated pulmonary artery pressures leading to right heart failure and death.

AIMS

The aim of this study was to use cluster analysis to describe the symptom profile in PAH and differences in the health outcomes of health status, health-related quality of life (HRQoL) and psychological states in the cluster groups.

METHODS

A cross-sectional descriptive design was used. A convenience sample completed a socio-demographic and clinical data form, a PAH Symptom Severity and Interference Scale, the Medical Outcomes Study Short Form (SF-36), the United States Cambridge Pulmonary Hypertension Outcome Review (US CAMPHOR) and the Short Form of the Profile of Mood States (POMS).

RESULTS

Of the 151 participants, the mean age was 53.5 ± 15.1 with the majority female (n = 128, 85%). Fifty-eight (41%) were disabled and 67 (44%) were Functional Class IV. The most prevalent symptoms were shortness of breath with exertion (n = 149, 99%) and fatigue (n = 144, 93%). Three clusters emerged: Cluster 1 diffuse symptoms (n = 93), Cluster 2 severe cardiopulmonary symptoms (n = 32) and Cluster 3 moderate cardiopulmonary symptoms (n = 26). Overall, on the SF-36 the participants had poor general health, reduced physical function, role physical, vitality, and a low composite score for physical health. On the POMS the sample had limited vigor and increased fatigue. Cluster 2 Severe Cardiopulmonary Symptoms had worse SF-36, US CAMPHOR and POMS scores than the other cluster groups.

CONCLUSIONS

Patients with PAH are experiencing a constellation of symptoms that are interfering with their life and emerging clusters were present.

摘要

背景

肺动脉高压(PAH)的特征是肺动脉压力升高,导致右心衰竭和死亡。

目的

本研究旨在使用聚类分析描述 PAH 的症状特征,并比较聚类组之间健康状况、健康相关生活质量(HRQoL)和心理状态的健康结果差异。

方法

采用横断面描述性设计。方便抽样法选取了 151 名参与者,他们填写了社会人口统计学和临床数据表格、PAH 症状严重程度和干扰量表、医疗结局研究短式量表(SF-36)、美国剑桥肺动脉高压预后评价(US CAMPHOR)和心境状态短式量表(POMS)。

结果

在 151 名参与者中,平均年龄为 53.5 ± 15.1 岁,大多数为女性(n = 128,85%)。58 人(41%)残疾,67 人(44%)为功能分级 IV 级。最常见的症状是运动时呼吸困难(n = 149,99%)和疲劳(n = 144,93%)。共出现 3 个聚类:聚类 1 弥漫性症状(n = 93)、聚类 2 严重心肺症状(n = 32)和聚类 3 中度心肺症状(n = 26)。总体而言,SF-36 得分显示参与者的一般健康状况较差,身体功能、角色身体、活力降低,身体健康综合得分较低。POMS 得分显示参与者的活力有限,疲劳感增加。与其他聚类组相比,聚类 2 严重心肺症状组的 SF-36、US CAMPHOR 和 POMS 评分更差。

结论

PAH 患者经历了一系列干扰生活的症状,并且出现了聚类现象。

相似文献

1
Cluster analysis of symptoms in pulmonary arterial hypertension: a pilot study.肺动脉高压症状聚类分析:一项初步研究。
Eur J Cardiovasc Nurs. 2012 Mar;11(1):51-61. doi: 10.1177/1474515111429649. Epub 2012 Jan 11.
2
Sleep disturbance, symptoms, psychological distress, and health-related quality of life in pulmonary arterial hypertension.肺动脉高压患者的睡眠障碍、症状、心理困扰及健康相关生活质量
Eur J Cardiovasc Nurs. 2015 Oct;14(5):423-30. doi: 10.1177/1474515114537951. Epub 2014 May 27.
3
Symptom Interference Severity and Health-Related Quality of Life in Pulmonary Arterial Hypertension.肺动脉高压中的症状干扰严重程度与健康相关生活质量
J Pain Symptom Manage. 2016 Jan;51(1):25-32. doi: 10.1016/j.jpainsymman.2015.07.012. Epub 2015 Aug 20.
4
Symptom Prevalence, Symptom Severity, and Health-Related Quality of Life Among Young, Middle, and Older Adults With Pulmonary Arterial Hypertension.年轻、中年和老年肺动脉高压患者的症状患病率、症状严重程度及健康相关生活质量
Am J Hosp Palliat Care. 2016 Apr;33(3):214-21. doi: 10.1177/1049909114554079. Epub 2014 Oct 7.
5
Health-related quality of life and psychological states in patients with pulmonary arterial hypertension.肺动脉高压患者的健康相关生活质量和心理状态。
J Cardiovasc Nurs. 2014 Mar-Apr;29(2):178-84. doi: 10.1097/JCN.0b013e318275330d.
6
Emotional symptoms and quality of life in patients with pulmonary arterial hypertension.肺动脉高压患者的情绪症状和生活质量。
J Heart Lung Transplant. 2014 Aug;33(8):800-8. doi: 10.1016/j.healun.2014.04.003. Epub 2014 Apr 19.
7
Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertension.CAMPHOR 和 SF-36 在肺动脉高压中的心理计量学性能。
BMC Pulm Med. 2013 Jul 12;13:45. doi: 10.1186/1471-2466-13-45.
8
Symptom burden, quality of life, and attitudes toward palliative care in patients with pulmonary arterial hypertension: results from a cross-sectional patient survey.肺动脉高压患者的症状负担、生活质量和对姑息治疗的态度:一项横断面患者调查的结果。
J Heart Lung Transplant. 2012 Oct;31(10):1102-8. doi: 10.1016/j.healun.2012.08.010.
9
Development and initial psychometric properties of the Pulmonary Arterial Hypertension Symptom Scale (PAHSS).
Appl Nurs Res. 2015 Feb;28(1):42-7. doi: 10.1016/j.apnr.2014.04.001. Epub 2014 Apr 18.
10
Impact of psychological factors on the health-related quality of life of patients treated for pulmonary arterial hypertension.心理因素对肺动脉高压患者健康相关生活质量的影响。
J Psychosom Res. 2018 Feb;105:45-51. doi: 10.1016/j.jpsychores.2017.12.003. Epub 2017 Dec 6.

引用本文的文献

1
Dissecting contributions of pulmonary arterial remodeling to right ventricular afterload in pulmonary hypertension.剖析肺动脉重塑对肺动脉高压患者右心室后负荷的影响。
Bioeng Transl Med. 2025 Jun 26;10(4):e70035. doi: 10.1002/btm2.70035. eCollection 2025 Jul.
2
Exploring the Economic Burden of Pulmonary Arterial Hypertension and Its Relation to Disease Severity and Treatment Escalation: A Systematic Literature Review.探索肺动脉高压的经济负担及其与疾病严重程度和治疗升级的关系:一项系统文献综述
Pharmacoeconomics. 2025 Apr 17. doi: 10.1007/s40273-025-01492-1.
3
Relationships that perceived barriers to physical activity have with functional capacity and quality of life in patients with pulmonary hypertension.
肺动脉高压患者中,身体活动的感知障碍与功能能力和生活质量之间的关系。
J Bras Pneumol. 2025 Mar 31;51(1):e20240195. doi: 10.36416/1806-3756/e20240195. eCollection 2025.
4
Kidney transplantation in the presence of pulmonary hypertension: A clinical dilemma.肺动脉高压情况下的肾移植:临床困境。
Heliyon. 2024 Oct 11;10(20):e39074. doi: 10.1016/j.heliyon.2024.e39074. eCollection 2024 Oct 30.
5
Honokiol and Nicotinamide Adenine Dinucleotide Improve Exercise Endurance in Pulmonary Hypertensive Rats Through Increasing SIRT3 Function in Skeletal Muscle.霍诺酚醇和烟酰胺腺嘌呤二核苷酸通过增加骨骼肌中的 SIRT3 功能改善肺动脉高压大鼠的运动耐力。
Int J Mol Sci. 2024 Oct 29;25(21):11600. doi: 10.3390/ijms252111600.
6
Barriers to and facilitators of physical activity in pediatric pulmonary hypertension.小儿肺动脉高压患者身体活动的障碍与促进因素
Pulm Circ. 2024 Oct 16;14(4):e70000. doi: 10.1002/pul2.70000. eCollection 2024 Oct.
7
Sleep Quality and Its Predictors among Dyspnea, Fatigue and Exercise Capacity in Pulmonary Arterial Hypertension.肺动脉高压患者呼吸困难、疲劳及运动能力中的睡眠质量及其预测因素
Acta Cardiol Sin. 2024 Sep;40(5):618-626. doi: 10.6515/ACS.202409_40(5).20240712A.
8
Dissecting contributions of pulmonary arterial remodeling to right ventricular afterload in pulmonary hypertension.剖析肺动脉重塑对肺动脉高压患者右心室后负荷的影响。
bioRxiv. 2024 Aug 19:2024.08.18.608471. doi: 10.1101/2024.08.18.608471.
9
Creating a digital approach for promoting physical activity in pediatric pulmonary hypertension: A framework for future interventions.创建促进小儿肺动脉高压患者身体活动的数字方法:未来干预框架。
Pulm Circ. 2024 Jul 2;14(3):e12402. doi: 10.1002/pul2.12402. eCollection 2024 Jul.
10
Usefulness of the Duke Activity Status Index to Assess Exercise Capacity and Predict Risk Stratification in Patients with Pulmonary Arterial Hypertension.杜克活动状态指数在评估肺动脉高压患者运动能力及预测危险分层中的应用价值
J Clin Med. 2023 Apr 7;12(8):2761. doi: 10.3390/jcm12082761.